![]() | Walter E StammShow email addressDepartment of Medicine, University of Washington, Seattle, WA, USA. | Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA. | Deceased. ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
Walter E Stamm:Expert Impact
Concepts for whichWalter E Stammhas direct influence:Chlamydia trachomatis,Urinary tract,Urinary tract infection,Escherichia coli,Tract infections,Urinary tract infections,Antimicrobial resistance,Acute pyelonephritis.
Walter E Stamm:KOL impact
Concepts related to the work of other authors for whichfor which Walter E Stamm has influence:Chlamydia trachomatis,Urinary tract,Escherichia coli,Clostridium difficile,Bacterial vaginosis,Asymptomatic bacteriuria,Antimicrobial resistance.
KOL Resume for Walter E Stamm
Year | |
---|---|
2014 | Department of Medicine, University of Washington, Seattle, WA, USA. |
2013 | Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA. Deceased. |
2011 | Department of Medicine, University of Washington |
2010 | Department of Medicine, University of Washington, Seattle, Washington Professor of Medicine Emeritus, Owen R. Cheatham Professor of the Sciences Emeritus, Chief of Infectious Diseases Emeritus, University of Virginia Health Center, Charlottesville, Virginia |
2009 | Division of Allergy and Infectious Disease, the University of Washington, Seattle, Washington Medicine and |
2008 | Department of Medicine, Division of Infectious Diseases, University of Washington Medical Center, University of Washington School of Medicine, Seattle |
2007 | Division of Allergy and Infectious Disease, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195 From the *University of Washington, Department of Medicine, Seattle, Washington; the †Indiana University School of Medicine, Department of Medicine, Indianapolis, Indiana; the ‡State University of New York, Department of Medicine, Brooklyn, New York; and the §ActivBiotics, Inc., Lexington, Massachusetts University of Washington, Seattle (Ms Roberts and Dr Stamm). |
2006 | Division of Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington 98195 From the *Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and the †Department of Medicine, University of Washington School of Medicine, Seattle, Washington Centers for Disease Control, MS C17, 1600 Clifton Road, Atlanta, GA 30333, USA |
2005 | University of Washington, Seattle; Division of Infectious Diseases, Department of Medicine, and |
2004 | 1University of California, San Francisco, California 2University of Washington, Seattle, Washington 3University of Pittsburgh, Pittsburgh, Pennsylvania 4University of Virginia, Charlottesville, Virginia 5Division of Research, Kaiser Permanente, Oakland, California 6Northwestern University, Chicago, Illinois Division of Infectious Diseases, University of Washington, Seattle, Washington |
2003 | Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington |
2002 | Microbiology Laboratory, Kupat Holim, Tel-Hanan, Israel Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle 98195, USA. Allergy and Infectious Diseases, University of Washington, Box 356523, Seattle, WA, USA |
2001 | Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle; From University of Washington, Seattle, Washington. University of Washington School of Medicine, Seattle |
2000 | Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle |
1999 | Departments of Medicine and Pathobiology, Division of Allergy and Infectious Diseases, University of Washington, Department of Molecular Medicine, Northwest Hospital and Biomembrane Institute, Seattle, Washington |
1998 | University of Washington, Seattle, Washington, and |
1997 | Department of Medicine, University of Washington Medical Center (WES), Seattle, Washington |
Concept | World rank |
---|---|
ompa polymorphism | #1 |
strains versus | #1 |
32fold 00078 chg | #1 |
7 trimethoprimsulfamethoxazole | #1 |
ruti young women | #1 |
aerobactin determinants strains | #1 |
trachomatis therapy | #1 |
uncomplicated cystitis isolation | #1 |
std bacterial | #1 |
resistance rates 20 | #1 |
catheter‐associated uti | #1 |
menses gonococcal coinfection | #1 |
immunity 32 | #1 |
sameserovar recurrences persistence | #1 |
transurethrally challenged mice | #1 |
laboratories 1998 | #1 |
nosocomial acquisition difficile | #1 |
crispatus recurrent uti | #1 |
fungal doxycycline | #1 |
week university cohort | #1 |
infection bacteriuria | #1 |
selective emergence resistance | #1 |
culture urethral | #1 |
2 lcr | #1 |
women cervical cap | #1 |
electron upec | #1 |
previous uti | #1 |
singledose rifalazil treatment | #1 |
1937 women | #1 |
facs dyes humans | #1 |
nonsecretor genotype | #1 |
50 ofloxacintreated patients | #1 |
drug gels chg | #1 |
healthy women cases | #1 |
specificity chlamydiazyme test | #1 |
bartonella quintana patients | #1 |
rectal flora women | #1 |
patientyear postcoital administration | #1 |
strains prostatitis | #1 |
infectionsjama relapsing infection | #1 |
chlamydia cultures | #1 |
homosexual management | #1 |
cases plan databases | #1 |
95 recurrent uti | #1 |
estriol nm | #1 |
d2a21 peptide mcc | #1 |
rifampin binding site | #1 |
ciprofloxacin vaginal colonization | #1 |
lcr yield | #1 |
uncomplicated cystitis tmpsmx | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by Walter E Stamm
Increasing Prevalence of Antimicrobial Resistance Among Uropathogens Causing Acute Uncomplicated Cystitis in Women
[ PUBLICATION ]
CONTEXT: Guidelines for the management of acute uncomplicated cystitis in women that recommend empirical therapy in properly selected patients rely on the predictability of the agents causing cystitis and knowledge of their antimicrobial susceptibility patterns.
OBJECTIVE: To assess the prevalence of and trends in antimicrobial resistance among uropathogens causing well-defined episodes of acute uncomplicated cystitis in a large population of women.
DESIGN: Cross-sectional survey of ...
Known for Acute Uncomplicated Cystitis | Antimicrobial Resistance | Increasing Prevalence | Coli Isolates | Uropathogens Causing |
CONTEXT: The optimal antimicrobial regimen and treatment duration for acute uncomplicated pyelonephritis are unknown.
OBJECTIVE: To compare the efficacy and safety of a 7-day ciprofloxacin regimen and a 14-day trimethoprim-sulfamethoxazole regimen for the treatment of acute pyelonephritis in women.
DESIGN: Randomized, double-blind comparative trial conducted from October 1994 through January 1997.
SETTING: Twenty-five outpatient centers in the United States.
PATIENTS: Of 378 enrolled ...
Known for 7 Day | Uncomplicated Pyelonephritis | Trimethoprim Sulfamethoxazole | Patients Drug | 14 Women |
Effect of Expedited Treatment of Sex Partners on Recurrent or Persistent Gonorrhea or Chlamydial Infection
[ PUBLICATION ]
BACKGROUND: Many sex partners of persons with gonorrhea or chlamydial infections are not treated, which leads to frequent reinfections and further transmission.
METHODS: We randomly assigned women and heterosexual men with gonorrhea or chlamydial infection to have their partners receive expedited treatment or standard referral. Patients in the expedited-treatment group were offered medication to give to their sex partners, or if they preferred, study staff members contacted partners and ...
Known for Chlamydial Infection | Sex Partners | Patients Gonorrhea | Expedited Treatment | Standard Partner Referral |
Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM)
[ PUBLICATION ]
OBJECTIVE: To determine the prevalence of sexually transmitted diseases (STD) and incidence of and risk factors for STD, including HIV-1, among a cohort of HIV-negative men who have sex with men (MSM).
SETTING: Seattle, Washington, United States.
PARTICIPANTS: Prospective cohort of 578 HIV-negative MSM in which risk factors for acquiring a STD over 12 months follow-up were evaluated using a cumulative incidence analysis.
MAIN OUTCOME MEASURES: Baseline tests obtained were: herpes simplex ...
Known for Sexually Transmitted Diseases | Hsv1 Hsv2 | Msm Male Humans | Incidence Hiv | Male Prevalence |
Women with a history of recurrent Escherichia coli urinary tract infections (UTIs) are two to three times more likely to be nonsecretors of histo-blood group antigens than are women without such a history. Further, uroepithelial cells from women who are nonsecretors show enhanced adherence of uropathogenic E. coli compared with cells from secretors. To investigate the hypothesis that nonsecretors express unique receptors for uropathogenic E. coli related to their genetic background, we ...
Known for Uropathogenic Escherichia | Epithelial Cells | Nonsecretors Secretors | Sgg Dsgg | Urinary Tract Infections |
Few evaluations of tests for Chlamydia trachomatis have compared nucleic acid amplification tests (NAATs) with diagnostic tests other than those by culture. In a five-city study of 3,551 women, we compared the results of commercial ligase chain reaction (LCR) and PCR tests performed on cervical swabs and urine with the results of PACE 2 tests performed on cervical swabs, using independent reference standards that included both cervical swabs and urethral swab-urine specimens. Using ...
Known for Cervical Swabs | Amplification Tests | Chlamydia Trachomatis | Nucleic Acid | Dna Probe |
To define the urovirulence properties of Escherichia coli strains producing prostatitis, E. coli strains isolated from men with acute (7 strains) or chronic (23) prostatitis were compared with E. coli isolates from women with pyelonephritis (30), acute cystitis (60), or complicated urinary tract infection (UTI; 30). Strains from prostatitis patients were significantly more likely to express hemolysin than were strains causing complicated UTI (73% vs. 43%; P = .02) and more often ...
Known for Coli Strains | Escherichia Infections Escherichia | Causing Prostatitis | Proteins Female Fimbriae | Urinary Tract |
BACKGROUND: High rates of resistance to trimethoprim-sulfamethoxazole (TMP-SMX) among uropathogenic Escherichia coli are recognized, and concerns exist about emerging fluoroquinolone resistance.
METHODS: Adults presenting to 11 US emergency departments with (1) flank pain and/or costovertebral tenderness, (2) temperature >38 degrees C, and (3) a presumptive diagnosis of pyelonephritis were enrolled; patients for whom 1 uropathogen grew on culture were analyzed. Epidemiologic and clinical ...
Known for Escherichia Coli | Uncomplicated Pyelonephritis | Resistance Ciprofloxacin | Tmp Smx | Infection Patients |
To assess the role of aerobactin as a virulence factor among uropathogenic Escherichia coli, we determined the prevalence, location, and phenotypic expression of aerobactin determinants among 58 E. coli strains causing bacteremic urinary tract infections. We correlated the presence of the aerobactin system with antimicrobial-agent resistance, the presence and phenotypic expression of other uropathogenic virulence factor determinants (P fimbriae, hemolysin, and type 1 fimbriae), and ...
Known for Virulence Factor | Bacterial Genes | Microbial Escherichia | Aerobactin Determinants | Strains Patients |
PURPOSE: Lactobacillus crispatus strain CTV-05 is a vaginal probiotic proposed for use in women with recurrent urinary tract infection to reduce vaginal colonization with Escherichia coli and the risk of urinary tract infection. However, the ability of this probiotic strain to adhere to the target mucosa, vaginal epithelial cells, has not been assessed in women with recurrent urinary tract infection. We measured the adherence of L. crispatus strain CTV-05 to vaginal epithelial cells ...
Known for Vaginal Epithelial Cells | Urinary Tract | Lactobacillus Crispatus | Women Recurrent | Sexual Activity |
Epidemic Lymphogranuloma Venereum During Epidemics of Crack Cocaine Use and HIV Infection in the Bahamas
[ PUBLICATION ]
BACKGROUND: Since the early 1980s, the Bahamas has experienced sequential epidemics of freebase/crack cocaine use, genital ulcer-inguinal adenopathy disease (GUD), and heterosexual HIV infection.
GOAL: To prospectively define the etiology of GUD in patients at the Princess Margaret Hospital during outbreaks of crack cocaine use, GUD, and HIV infection in the Bahamas.
STUDY DESIGN: In Nassau, 47 consecutive patients with GUD underwent serologic testing for syphilis and for infections with ...
Known for Hiv Infection | Crack Cocaine | Lymphogranuloma Venereum | Gud Bahamas | Pcr Trachomatis |
Bartonella (Rochalimaea) quintana Bacteremia in Inner-City Patients with Chronic Alcoholism
[ PUBLICATION ]
BACKGROUND: Bartonella (Rochalimaea) quintana is a fastidious gram-negative bacterium known to cause trench fever, cutaneous bacillary angiomatosis, and endocarditis. Between January and June 1993 in Seattle, we isolated B. quintana from 34 blood cultures obtained from 10 patients not known to be infected with the human immunodeficiency virus (HIV).
METHODS: After identifying the isolates as B. quintana by direct immunofluorescence and DNA-hybridization studies, we determined strain ...
Known for Quintana Bacteremia | Blood Cultures | Trench Fever | 10 Patients | Bartonella Rochalimaea |